Structural and biochemical basis of ROC-dependent activation of LRRK2

Area of Science:

• Biochemistry
• Structural Biology
• Neuroscience

Background:

• Mutations in leucine-rich repeat kinase 2 (LRRK2) are the leading genetic cause of familial Parkinson's disease.
• The precise molecular mechanisms regulating LRRK2 activation, particularly the role of its Ras of complex proteins (ROC) GTPase domain, remain unclear.

Purpose of the Study:

• To elucidate the structural and mechanistic basis of LRRK2 activation.
• To define the role of ROC domain conformational changes in regulating LRRK2 kinase activity.

Main Methods:

• Cryo-electron microscopy (Cryo-EM) of full-length LRRK2.
• X-ray crystallography of the LRRK2 ROC domain.
• Structure-guided biochemical perturbations, including disulfide engineering.

Main Results:

• Cryo-EM revealed three distinct conformational states (autoinhibited, intermediate, activated) of monomeric LRRK2, suggesting an intrinsic intramolecular activation pathway.
• X-ray crystallography identified conformational plasticity within the ROC GTPase switch regions.
• Disulfide engineering demonstrated functional coupling between R1441 and Switch II, directly impacting GTPase activity and mimicking disease mutations.

Conclusions:

• The ROC domain acts as a dynamic conformational engine driving LRRK2 activation through a multistep intramolecular mechanism.
• Pathogenic LRRK2 mutations likely promote aberrant kinase activation by disrupting this intrinsic regulatory pathway.
• These findings provide crucial mechanistic insights into LRRK2 function and Parkinson's disease pathogenesis.